February 13, 2025
Deloitte Access Economics - Migraine in Australia Whitepaper
In 2018, Deloitte Access Economics prepared a whitepaper for Novartis Australia. Migraine is a neurological condition that affects 4.9 million Australians. Migraine is characterised by recurrent attacks of moderate to severe...
Read moreFebruary 12, 2025
Migraine Australia 25-26 Pre- Budget Submission
Migraine is the most underfunded, underdiagnosed, and undertreated condition in the country. People with migraine face significant challenges in accessing equitable health care, and no one who is unwell should have...
Read more